Efficiency of human immunodeficiency virus transmission through injections and other medical procedures: Evidence, estimates, and unfinished business

Infection Control and Hospital Epidemiology

Volumn 27, Issue 9, 2006, Pages 944-952

  Gisselquist, David ^a   Upham, Garance ^b   Potterat, John J ^a  

^a Bells Consultants ^*  (United States)

^b Bells Consultants   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHILD; CONTROLLED STUDY; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IATROGENIC DISEASE; INJECTION; INSTRUMENT STERILIZATION; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; RISK FACTOR; SEROCONVERSION; SURVIVAL; VIRUS SURVIVAL; VIRUS TRANSMISSION;

EID: 33749038922     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/506408     Document Type: Article

References (64)

1. Allard R. A mathematical model to describe the risk of infection from sharing injection equipment. J Acquir Immune Defic Syndr 1990; 3:1010-1016.
2. Heymann DL, Edstrom K. Strategies for AIDS prevention and control in sub-Saharan Africa. AIDS 1991; 5(Suppl 1):S197-S208.
3. Hoelscher M, Riedner G, Hemed Y, Wagner H-U, Korte R, von Sonnenburg F. Estimating the number of HIV transmissions through reused syringes and needles in the Mbeya Region, Tanzania. AIDS 1994; 8:1609-1615.
4. Aylward B, Kane M, McNair-Scott R, Hu DH. Model-based estimates of the risk of human immunodeficiency virus and hepatitis B virus transmission through unsafe injections. Int J Epidemiol 1995; 24:446-452.
5. Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M. Transmission of hepatitis B, hepatitis C, and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull WHO 1999; 77:801-807.
6. Ekwueme DU, Weniger GB, Chen RT. Model-based estimates of risks of disease transmission and economic costs of seven injection devices in sub-Saharan Africa. Bull WHO 2002; 80:859-870.
7. Hauri AJ, Armstrong GL, Hutin YJF. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS 2004; 15:7-16.
8. Schmid GP, Buve A, Mugyenyi P, et al. Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet 2004; 363:482-488.
9. Kaplan EH, Heimer R. A model-based estimate of HIV infectivity via needle sharing. J Acquir Immune Defic Syndr 1992; 5:1116-1118.
10. Hudgens MG, Longini IM Jr, Halloran ME, et al. Estimating the transmission probability of human immunodeficiency virus in injecting drug users in Thailand. Appl Statist 2001; 50:1-14.
11. Hudgens MG, Longini IM Jr, Vanichsensi S, et al. Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand. Am J Epidemiol 2002; 155:159-168.
12. Baggaley RF, Boily M-C, White RG, Alary M. Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis. AIDS 2006; 20:805-812.
13. Porco TC, Aragon TJ, Fernyak SE, et al. Quantitative Risk Assessment for Needle Reuse at a Phlebotomy Center: Parameter Estimation, Scenario Evaluation, Sensitivity Analysis. May 22, 2000. San Francisco: San Francisco Department of Public Health. Available at: http://www.dph.sf.ca.us/Reports/ndlreuse.pdf. Accessed August 1, 2006.
14. Avila C, Stetler HC, Sepúlveda J, et al. The epidemiology of HIV transmission among paid plasma donors, Mexico City, Mexico. AIDS 1989; 3:631-633.
15. Banerjee K, Rodrigues J, Israel Z, Kulkarni S, Thakar M. Outbreak of HIV seropositivity among commercial plasma donors in Pune, India [letter]. Lancet 1989; 2:166.
16. Pokrovski VV, Eramova IIU, Deulina MO, et al. An intrahospital outbreak of HIV infection in Elista [in Russian]. Z Microbiol Epidemiol Immunobiol 1990; 4:17-23.
17. Pokrovsky W. Localization of nosocomial outbreak of HIV infection in southern Russia in 1988-89. In: Proceedings of the Eighth International Conference on AIDS; July 19-24, 1992; Amsterdam, The Netherlands. Abstract PoC 4138.
18. Bobkov A, Garaev MM, Rzhaninova A, et al. Molecular epidemiology of HIV-1 in the former Soviet Union: analysis of env V3 sequences and their correlation with epidemiologic data. AIDS 1994; 8:619-624.
19. Sauhat SR, Kotova EA, Prokopenkova SA, et al. Risk factors for HIV transmission in hospital outbreak [abstract]. In: Proceedings of the Eighth International Conference on AIDS; July 19-24, 1992; Amsterdam, The Netherlands. Abstract PoC 4288.
20. Hersh BS, Popovici F, Jezek Z, et al. Risk factors for HIV infection among abandoned Romanian children. AIDS 1993; 7:1617-1624.
21. Patrascu IV, Dumitrescu O. The epidemic of human immunodeficiency virus infection in Romanian children. AIDS Res Hum Retroviruses 1993; 9:99-104.
22. Hassan NF, El Ghorab NM, Rehim MS, et al. HIV infection in renal dialysis patients in Egypt [letter]. AIDS 1994; 8:853.
23. Pugliese G. HIV transmission reported in dialysis center. Infect Cont Hosp Epidemiol 1995; 16:482.
24. Wu Z, Rou K, Detels R. Prevalence of HIV infection among former commercial plasma donors in rural eastern China. Health Policy Plan 2001; 16:41-46.
25. Zhang K, Gui X, Su B, Chen Z, Zhang L. High prevalence of HIV infection among women and their children in Henan Province, China [letter]. J Acquir Immune Defic Syndr 2003; 33:649-650.
26. Ministry of Health, People's Republic of China. 2005 Update on the HIV/AIDS Epidemic and Response in China. Geneva: UNAIDS; 2006.
27. Su B, Liu L, Wang F, et al. HIV-1 subtype B dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China. AIDS 2003; 17:2515-2520.
28. Beach MV. "Blood heads" and AIDS haunt China's countryside. Lancet 2001; 357:49.
29. Shan H, Wang J-X, Ren F-R, et al. Blood banking in China. Lancet 2002; 360:1770-1775.
30. Visco-Comandini U, Cappiello G, Luizzi G, et al. Monophyletic HIV type 1 CRF02-AG in a nosocomial outbreak in Benghazi, Libya. AIDS Res Hum Retroviruses 2002; 18:727-732.
31. Quadri R, Yerli S, Posfay-Barbe K, et al. Outbreak of blood-borne viral infections in children attending a single hospital [abstract]. Hepatology 2000; 32:281A.
32. Yerly S, Quadri R, Negro F, et al. Nosocomial outbreak of multiple bloodborne viral infections. J Infect Dis 2001; 184:369-372.
33. Shields J. Patient-to-patient transmission of HIV [letter]. Lancet 1994; 343:415.
34. Gisselquist D. Estimating HIV-1 transmission efficiency through unsafe medical injections. Int J STD AIDS 2002; 13:152-159.
35. Bell DM. Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. Am J Med 1997; 102(Suppl 5B):9-15.
36. Gerberding JL. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure; final report from a longitudinal study. J Infect Dis 1994; 170:1410-1417.
37. Tokars JI, Marcus R, Culver DH, et al. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposures to HIV-infected blood. Ann Intern Med 1993; 118:913-919.
38. Kaplan EH. Needles that kill: modeling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries. Rev Infect Dis 1989; 11:289-298.
39. Van de Perre P, Diakhate L, Watson-Williams J. Prevention of blood-borne transmission of HIV. AIDS 1997; 11(Suppl B):S89-S98.
40. Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med 1997; 337:1485-1490.
41. Goletti D, Weissman D, Jackson RW, et al. Effect of Mycobacterium tuberculosis on HIV replication. J Immunol 1996; 157:1271-1278.
42. Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous heterosexual, HIV-1 discordant couples in Rakai, Uganda. Lancet 2001; 357:1149-1153.
43. Piatak M, Saag MS, Yang LC, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993; 259:1749-1754.
44. Richardson BA, Mbori-Ngacha D, Lavreys L, et al. Comparison of human immunodeficiency virus type 1 viral loads in Kenyan women, men, and infants during primary and early infection. J Virol 2003; 77:7120-7123.
45. Gisselquist D, Potterat JJ, Brody S. HIV transmission during paediatric health care in sub-Saharan Africa: risks and evidence. S Afr Med J 2004; 94:109-116.
46. Heimer R, Abdala N. Viability of HIV-1 in syringes: implications for interventions among injection drug users. AIDS Reader 2000; 10:410-417.
47. Grund J-PC, Stern LS. Residual blood in syringes: size and type of syringe are important. AIDS 1991; 5:1532-1533.
48. Hughes RR. Post-penicillin jaundice. BMJ 1946; 2:685-688.
49. Rich JD, Dickinson BP, Carney JM, Fisher A, Heimer R. Detection of HIV-I nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection. AIDS 1998; 12:2345-2350.
50. Kanitakis J, Escaich S, Trepo C, Thivolet J. Detection of human immunodeficiency virus-DNA and RNA in the skin of HIV-infected patients using the polymerase chain reaction. J Invest Dermatol 1991; 97:91-96.
51. Blauvelt A. The role of skin dendritic cells in the initiation of human immunodeficiency virus infection. Am J Med 1997; 102(Suppl 5B):16-20.
52. Soto-Ramirez LE, Renjifo B, McLane MF, et al. HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 1996; 271:1291-1293.
53. Essex M, Renjifo B, Peña-Cruz V, et al. Different subtypes of HIV-1 and cutaneous dendritic cells: response [letter]. Science 1997; 278:787-788.
54. Evans RJ, Spooner ETC. A possible mode of transfer of infection by syringes used for mass inoculation. BMJ 1950; 2:185-188.
55. Hutin Y, Hauri A, Chiarello L, et al. Best infection control practices for intradermal, subcutaneous, and intramuscular needle injections. Bull WHO 2003; 81:491-500.
56. Resnick L, Veren K, Salahuddin SZ, Tondreau S, Markham PD. Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments. JAMA 1986; 255:1887-1891.
57. Lakshman M, Nichter M. Contamination of medicine injection paraphernalia used by registered medical practitioners in south India: an ethnographic study. Soc Sci Med 2000; 51:11-28.
58. Birungi H, Asiimwe D, Whyte SR. Injection Use and Practices in Uganda (WHO/DAP/94.18). Geneva, Switzerland: World Health Organization; 1994.
59. Druce JD, Locarnini SA, Birch CJ. Syringe cleaning techniques and transmission of HIV [letter]. AIDS 1995; 9:1105-1107.
60. Abdala N, Cleghorn AA, Carney JM, Heimer J. Can HIV-1-contaminated syringes be disinfected. J Acquir Immune Defic Syndr 2001; 28:487-494.
61. Van Bueren J, Simpson RA, Salman H, Farrelly HD, Cookson BD. Inactivation of HIV-1 by chemical disinfectants: sodium hypochlorite. Epidemiol Infect 1995; 115:567-579.
62. Contoreggi C, Jones S, Simpson P, Lange WR, Meyer WA III. Effects of varying concentrations of bleach on in vitro HIV-1 replication and the relevance to injection drug use. Intervirology 2000; 43:1-5.
63. Lakshmi R. India's vaccines come with risk: dirty needles used for immunization can spread other diseases. Washington Post February 9, 2005: A18.
64. Hu DJ, Kane MA, Heymann DL. Transmission of HIV, hepatitis B virus, and other bloodborne pathogens in health settings: a review of risk factors and guidelines for prevention. Bull WHO 1991; 69:623-630.